Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2015-08-23 Notice of Dividend Amou…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
EXCHANGE RATE FOR UPCOMING DIVIDEND PAYMENT 1 page
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement regarding the exchange rate for an upcoming dividend payment and details about the dividend amount and payment dates. It does not contain any financial statements, detailed financial performance data, or comprehensive report content. The document length is only 2722 characters, which is quite short and typical for a dividend announcement. It explicitly discusses dividend payment details, exchange rates, and payment dates, which aligns with the definition of a Notice of Dividend Amount. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2015-08-23 English
Form 10-K & Annual Report For the Year Ended June 30, 2015 95 pages 337.9KB
Annual Report Classification · 100% confidence The document is titled 'FORM 10-K' and is described as an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended June 30, 2015. It includes detailed sections typical of an annual report such as Business, Risk Factors, Legal Proceedings, Management's Discussion and Analysis, Consolidated Financial Statements, and Executive Compensation. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial and operational information confirms this is the official yearly report covering company activity and full financial performance. FY 2015
2015-08-09 English
Appendix 3B 8 pages 248.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about securities issued or repurchased, number of securities, terms, issue price, and purpose related to share repurchase programs. The document references ASX rules and is clearly an announcement related to capital changes, specifically share repurchases and securities issuance. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is a formal announcement of capital changes and share repurchase activity, fitting the category of Share Issue/Capital Change.
2015-08-09 English
Financial Results for the Fourth Quarter & Fiscal Year 2015 7 pages 281.4KB
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of ResMed Inc.'s financial results for the fourth quarter and fiscal year 2015. It includes comprehensive financial data such as revenue, net income, earnings per share, operating expenses, and cash flow. It also discusses share repurchases, dividend increases, and provides a webcast for further discussion. The presence of detailed financial statements and analysis for a quarterly period indicates this is a comprehensive interim/quarterly financial report rather than a brief earnings release or a simple announcement. The document length (15,000 characters) and the inclusion of substantive financial data confirm it is not merely an announcement of a report but the report itself. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q4 2015
2015-07-30 English
Q4 & Fiscal Year-End, 2015 Results Conference Call 1
Earnings Release Classification · 95% confidence The document is a short announcement from ResMed about the upcoming release of its fourth quarter and fiscal year-end 2015 financial results. It provides details about the timing of the earnings release, the webcast, and replay information. There is no actual financial data or detailed report content included. The document is essentially a notice about when the earnings results will be announced and how to access the webcast. According to the MENU VS MEAL RULE, such a short announcement that states when and how the report will be released is classified as an Earnings Release (ER) announcement. However, since it does not contain the actual financial results but only the announcement of the upcoming release, it fits best as an Earnings Release (ER) type, which is the initial announcement of quarterly/periodical financial results (key highlights only). The document is not a full transcript or detailed report, so it is not a Call Transcript or Interim Report. Therefore, the classification is ER with high confidence. FY 2015
2015-07-02 English
ResMed FORM SD 8 pages 223.0KB
Regulatory Filings Classification · 100% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the calendar year ended December 31, 2014. It includes detailed information about the company's due diligence process, supply chain analysis, and conflict minerals reporting as required by the Securities Exchange Act of 1934, Section 13(p), Rule 13p-1. The document is not an annual report, earnings release, or any other financial report but a specialized regulatory disclosure focused on conflict minerals compliance. This type of filing is best classified under Regulatory Filings (RNS) as it is a specific compliance report filed with the SEC that does not fit into other categories like Annual Report or Audit Report.
2015-05-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.